ArticleTranslational vision science & technology2025
Thermal Tissue Modeling of the Ciliary Body With Continuous Wave Transscleral Cyclophotocoagulation and Transscleral Laser Therapy Using MicroPulse Technology.
Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Safety and efficacy of micropulse transscleral laser therapy for glaucoma: a two-year follow-up.International journal of ophthalmology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to evaluate thermal dynamics associated with continuous wave transscleral cyclophotocoagulation (CW-TSCPC) and transscleral laser therapy (TLT) using MicroPulse technology (MicroPulse TLT), such as temperature peak, exposure duration, and thermal spread in a simulated ciliary body (CB) using computer modeling. Methods: The simulation is a five-layer homogeneous slab model determined via the Monte Carlo methods. CW-TSCPC modeling was based on the G-Probe delivery device, incorporating parameters from classic and slow coagulation techniques. The MicroPulse TLT modeling was based on the revised MicroPulse P3 probe, aligned with International MicroPulse TLT Consensus Guidelines. For Micropulse TLT the modeling evaluates an arbitrary sample section along a sweep path during a sweep. Results: CW-TSCPC techniques elevated the CB peak temperature well above 100°C for 1.8 seconds with classic and 2.2 seconds with slow coagulation. The CB temperature was elevated above 60°C for 3.9 seconds with classic and 5.5 seconds with slow coagulation, both with a thermal affected zone of 2 mm. The MicroPulse TLT techniques elevated the CB temperature above 60°C for 0.15 to 1.1 seconds, affecting a CB zone of 0.6 mm to 1.2 mm depending on sweep speed and power. The MicroPulse TLT did not reach temperatures above 100°C. Conclusions: Modeling results indicate that MicroPulse TLT achieves lower, shorter duration peak temperatures, remaining below 100°C, and shows less thermal spread with more uniform heat distribution than CW-TSCPC. Main user settings for controlling CB temperature are sweep speed and power for MicroPulse TLT, and exposure time and power for CW-TSCPC. MicroPulse TLT's lower temperatures minimize the risk of permanent coagulative tissue necrosis, aligning with clinical literature supporting its enhanced safety profile over CW-TSCPC. Translational Relevance: Understanding thermal dynamics may aid in refining and optimizing both techniques to maximize outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.